Skip to main content

Julie Hallet

Dr. Hallet graduated from medical school in 2006 and completed her general surgery residency in 2011 at Université Laval in Québec City. During her surgical training, she entered the masters in sciences clinical epidemiology program at Université Laval as part of the clinical investigator program. After finishing her general surgery and research training, Dr. Hallet completed a surgical oncology fellowship at the University of Toronto during which she focused on hepato-pancreatico-biliary and upper gastrointestinal malignancies. She then obtained additional training in advanced minimally invasive and robotic liver and pancreatic surgery at the Institute of Research Against Digestive Cancer (IRCAD) in Strasbourg, France. During this time she also worked on the development of new image-guided research at the Institut de Chirurgie Guidée par l’Image (Institute for Image-Guided Surgery) from the Institut Hospitalier Universitaire de Strasbourg. 

Dr. Hallet’s surgical practice is devoted to hepato-biliary, pancreatic and upper gastrointestinal malignancies, with a clinical focus on minimally invasive and image-guided therapies, as well as neuroendocrine tumors. As a surgeon-investigator, her research focuses on health services population based research to examine processes, patterns of care, and outcomes of hepato-pancreato-biliary malignancies. In particular, Dr. Hallet is dedicated to improving care and outcomes of neuroendocrine tumors by identifying and implementing enablers to timely diagnosis and effective management. She is also working on evaluating outcomes of novel therapies for liver metastases, including the implementation of pre-operative 3D planning and intra-operative navigation programs.